US Stock MarketDetailed Quotes
APVO Aptevo Therapeutics
- 0.989
- -0.141-12.48%
Close May 3 16:00 ET
- 1.000
- +0.011+1.12%
Post 19:58 ET
3.55MMarket Cap-15P/E (TTM)
1.090High0.961Low2.01MVolume1.020Open1.130Pre Close2.06MTurnover55.98%Turnover RatioLossP/E (Static)3.59MShares80.96052wk High0.29P/B3.55MFloat Cap0.67052wk Low--Dividend TTM3.59MShs Float3911.600Historical High--Div YieldTTM11.41%Amplitude0.670Historical Low1.025Avg Price1Lot Size
Aptevo Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 44.20%-11.73M | 11.55%-5.25M | 9.51%-6.24M | -56.45%-4.8M | 189.23%4.57M | 3.03%-21.02M | -53.07%-5.94M | -31.55%-6.9M | 39.24%-3.07M | 31.81%-5.12M |
| Net income from continuing operations | -316.91%-17.41M | -27.17%-5.9M | 17.15%-6.33M | -128.38%-7.95M | 136.03%2.77M | 128.21%8.03M | 25.99%-4.64M | -9.25%-7.64M | 453.13%28.01M | -6.08%-7.7M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | 1,075.00%47K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -37.07%567K | -27.95%116K | -44.59%123K | -45.65%150K | -26.45%178K | -21.24%901K | -37.11%161K | -24.75%222K | -7.69%276K | -17.69%242K |
| Other non cash items | 100.03%10K | --0 | --0 | --0 | -99.41%10K | -611.04%-33.94M | -101.02%-23K | -101.38%-28K | -1,829.65%-35.58M | 468.01%1.69M |
| Change In working capital | 35.77%2.91M | 109.57%176K | -348.72%-485K | -32.32%2.53M | 1,280.00%690K | 180.75%2.14M | -510.96%-1.84M | 121.86%195K | 7,728.57%3.74M | 103.54%50K |
| -Change in receivables | 114.78%2.5M | --0 | --0 | --0 | 354.55%2.5M | 189.88%1.16M | -340.14%-2.5M | --0 | 551.96%3.11M | 1,157.69%550K |
| -Change in prepaid assets | -56.90%153K | 46.91%-146K | 44.66%-342K | 55.67%1.48M | -384.12%-841K | -18.58%355K | -157.89%-275K | 55.79%-618K | 47.37%952K | -58.49%296K |
| -Change in payables and accrued expense | 231.47%518K | -60.67%389K | -108.82%-76K | 176.99%1.11M | -13.91%-909K | 79.43%-394K | 549.55%989K | 88.62%862K | -3,345.24%-1.45M | 62.18%-798K |
| -Change in other current assets | -35.38%422K | 5.71%111K | 1.92%106K | -38.55%102K | -62.95%103K | -42.62%653K | -62.63%105K | -64.63%104K | -41.96%166K | 0.36%278K |
| -Change in other current liabilities | -286.34%-682K | -12.66%-178K | -13.07%-173K | -117.63%-168K | 40.94%-163K | 135.92%366K | 41.26%-158K | 40.93%-153K | 481.20%953K | -14.52%-276K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 44.20%-11.73M | 11.55%-5.25M | 9.51%-6.24M | -56.45%-4.8M | 189.23%4.57M | 3.03%-21.02M | -53.07%-5.94M | -31.55%-6.9M | 39.24%-3.07M | 31.81%-5.12M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 95.93%-29K | 0 | 69.23%-4K | ||||
| Net PPE purchase and sale | --0 | --0 | --0 | ---- | ---- | 95.93%-29K | --0 | 69.23%-4K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | --0 | --0 | 95.93%-29K | --0 | 69.23%-4K | 93.61%-25K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 329.28%6M | -49.22%3.05M | 968.80%4.34M | 115.14%481K | 62.05%-1.87M | -110.00%-2.62M | 294.99%6M | 83.45%-500K | -138.22%-3.18M | -120.62%-4.94M |
| Net issuance payments of debt | 71.74%-3.47M | --0 | --0 | --0 | 67.80%-3.47M | -16.27%-12.27M | ---500K | ---500K | ---500K | -2.06%-10.77M |
| Net common stock issuance | -7.30%6.43M | -51.59%3.15M | --1.2M | 10.32%481K | --1.6M | -32.24%6.93M | --6.5M | --0 | --436K | --0 |
| Proceeds from stock option exercised by employees | --3.05M | ---98K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net other financing activities | -100.37%-10K | ---2K | --0 | --0 | -100.14%-8K | -89.25%2.72M | --0 | --0 | -28.62%-3.11M | -82.80%5.83M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 329.28%6M | -49.22%3.05M | 968.80%4.34M | 115.14%481K | 62.05%-1.87M | -110.00%-2.62M | 294.99%6M | 83.45%-500K | -138.22%-3.18M | -120.62%-4.94M |
| Net cash flow | ||||||||||
| Beginning cash position | -51.11%22.64M | -15.36%19.11M | -29.93%21.01M | -30.13%25.33M | -51.12%22.64M | 8.86%46.3M | -57.70%22.58M | -51.38%29.98M | -38.33%36.25M | 8.86%46.3M |
| Current changes in cash | 75.78%-5.73M | -3,840.68%-2.21M | 74.38%-1.9M | 31.10%-4.32M | 126.79%2.69M | -727.94%-23.67M | 100.83%59K | 10.58%-7.4M | -318.42%-6.27M | -161.88%-10.05M |
| End cash Position | -25.32%16.9M | -25.32%16.9M | -15.36%19.11M | -29.93%21.01M | -30.13%25.33M | -51.11%22.64M | -51.11%22.64M | -57.70%22.58M | -51.38%29.98M | -38.33%36.25M |
| Free cash flow | 44.28%-11.73M | 11.55%-5.25M | 9.57%-6.24M | -55.19%-4.8M | 189.23%4.57M | 5.99%-21.05M | -48.55%-5.94M | -31.30%-6.9M | 43.15%-3.1M | 33.50%-5.12M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg